Nathan Boley

Nathan Boley is a cross-disciplinary scientist with expertise in statistics, functional genomics, machine learning, and software engineering, dedicated to eradicating diseases through innovative technologies. He is the founder and CEO of Ravel Biotechnology, focusing on developing advanced diagnostics.

He holds a Ph.D. in Biostatistics, an M.A. in Statistics, and a B.A. in Physics, Applied Math, and Statistics from the University of California, Berkeley. Nathan's professional journey includes roles at reputable organizations such as Freenome, Driver, and Stanford University, where he contributed significantly to computational biology, software engineering, and genetics research.

As a proven leader, Nathan Boley is known for his hands-on approach and entrepreneurial spirit. Through his work, he aims to revolutionize healthcare by creating efficient, accurate, and affordable diagnostic solutions to improve health outcomes worldwide.